SK

Scott D. Kuduk

Merck: 11 patents #6 of 1,083Top 1%
NT Novira Therapeutics: 5 patents #2 of 6Top 35%
📍 Spring House, PA: #2 of 39 inventorsTop 6%
🗺 Pennsylvania: #23 of 7,336 inventorsTop 1%
Overall (2018): #2,300 of 503,207Top 1%
16
Patents 2018

Issued Patents 2018

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDate
10155750 Amidoethyl azole orexin receptor antagonists Nigel J. Liverton, Yunfu Luo 2018-12-18
10150751 Pyrrolidine orexin receptor antagonists Nigel J. Liverton, Yunfu Luo, Jason W. Skudlarek 2018-12-11
10093669 Derivatives and methods of treating hepatitis B infections George D. Hartman 2018-10-09
10077264 Derivatives and methods of treating hepatitis B infections George D. Hartman 2018-09-18
10017504 Piperidine isoxazole and isothiazole orexin receptor antagonists Nigel J. Liverton, Douglas C. Beshore, Yunfu Luo, Na Meng, Tingting Yu 2018-07-10
10010539 Pyrazole, triazole and tetrazole orexin receptor antagonists Nigel J. Liverton, Douglas C. Beshore, Yunfu Luo, Na Meng 2018-07-03
10011595 Ethyldiamine orexin receptor antagonists Ronald Kim, Nigel J. Liverton, Gang Zhou 2018-07-03
10000499 Methyl diazepane orexin receptor antagonists Thomas S. Reger, Jason W. Skudlarek 2018-06-19
9994570 Bridged diazepane orexin receptor antagonists Thomas S. Reger, Anthony J. Roecker 2018-06-12
9987255 5,5-bicyclic oxazole orexin receptor antagonists Nigel J. Liverton, Thomas S. Reger, Jason W. Skudlarek 2018-06-05
9975876 2-pyridyloxy-3-ester-4-ether orexin receptor antagonists Jason W. Skudlarek 2018-05-22
9938276 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists Ronald Kim, Nigel J. Liverton, Gang Zhou 2018-04-10
9920038 Methyl oxazole orexin receptor antagonists Nigel J. Liverton, Yunfu Luo 2018-03-20
9890161 Derivatives and methods of treating hepatitis B infections George D. Hartman 2018-02-13
9884831 Azocane and azonane derivatives and methods of treating hepatitis B infections George D. Hartman 2018-02-06
9873671 Azepane derivatives and methods of treating hepatitis B infections George D. Hartman 2018-01-23